MinnagantiV.R., CunhaB.A.Infections associated with uremia and dialysis.Infect Dis Clin North Am2001; 15: 385–406.
6.
ChangC.F., KuoB.I., ChenT.L.. Infective endocarditis in maintenance hemodialysis patients: Fifteen years' experience in one medical center.J Nephrol2004; 17: 228–35.
7.
SpiesC., MadisonJ.R., SchatzI.J.Infective endocarditis in patients with end-stage renal disease: clinical presentation and outcome.Arch Intern Med2004; 164: 71–5.
8.
QuarlesL.D., RutskyE.A., RostandS.G.Staphylococcus aureus bacteremia in patients on chronic hemodialysis.Am J Kidney Dis1985; 6: 412–9.
9.
SaxenaA.K., PanhotraB.R., ChopraR.Advancing age and the risk of nasal carriage of Staphylococcus aureus among patients on long term hospital-based hemodialysis.Ann Saudi Med2004; 24: 337–42.
10.
Von EiffC., BeckerK., MachkaK., StammerH., PetersG.Nasal carriage as source of Staphylococcus aureus bacteremia.N Engl J Med2001; 344: 11–6.
11.
SaxenaA.K., PanhotraB.R., VenkateshappaC.K., SundaramD.S.. The impact of nasal carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus (MRSA & MSSA) on vascular access-related septicemia among patients with type-II diabetes on dialysis.Ren Fail2002; 24: 763–77.
MarajS., JacobsL.E., KungS.C.. Epidemiology and outcome of infective endocarditis in hemodialysis patients.Am J Med Sci2002; 324: 254–60.
15.
WatanakunakornC., BurketT.Infective endocarditis at a large community teaching hospital: a review of 210 episodes.Medicine1993; 72: 90–102.
16.
SinghM., BofingerA., CaveG.. Mycobacterium fortuitum endocarditis in a patient with chronic renal failure on hemodialysis.Pathology1992; 24: 197–200.
17.
SungurC., SungurA., GedikogluG.. Fatal Brucella melitensis endocarditis in a hemodialysis patient.Nephron1994; 67: 234–5.
18.
TurnerH.R., TaylorM.R., LockwoodW.R.Branhamella catarrhalis endocarditis in a patient receiving hemodialysis.South Med J1985; 78: 1021–2.
19.
Martinez-VeaA., CostaJ., GarciaC.. Corynebacterium group JK endocarditis in a haemodialysis patient.Nephrol Dial Transplant1993; 8: 177–9.
20.
ShivelyB.K., GuruleF.T., RoldanC.A., LeggettJ.H., SchillerN.B.Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis.J Am Coll Cardiol1991; 18: 391–7.
21.
SochowskiR.A., ChanK.L.Implication of negative results on a monoplane transesophageal echocardiographic study in patients with suspected infective endocarditis.J Am Coll Cardiol1993; 21: 216–21.
22.
BirminghamG.D., RahkoP.S., BallantyneF.Improved detection of infective endocarditis with transesophageal echocardiography.Am Heart J1992; 123: 774–81.
23.
LiuJ.W., SuY.K., LiuC.P., ChenJ.B.Nosocomial blood-stream infection in patients with endstage renal disease: excess length of hospital stay, extra cost and attributed mortality.J Hosp Infect2002; 50: 224–7.
24.
United States Renal Data System1999, Annual Data Report: Part VI. Causes of death.Am J Kidney Dis1999; 34: 87–94.
25.
RaadI., DarouicheR., DupuisJ.. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double blind trial. The Texas Medical Center Catheter Study Group.Ann Intern Med1997; 127: 267–74.
YuV.L., GoetzA., WagenerM.. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.N Engl J Med1986; 315: 91–6.
28.
BoelaertJ.R., Van LanduytH.W., GodardC.A.. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in hemodialysis patients.Nephrol Dial Transplant1993; 8: 235–9.
29.
JohnsonD.W., MacGinleyR., KayT.D., HawleyC.M., CampbellS.B., IsbelN.M., HollettP.A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters.Nephrol Dial Transplant2002; 17: 1802–7.
30.
VeenstraD.L., SaintS., SahaS.. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.JAMA1999; 281: 261–7.
31.
DarouichR.O., RaadI.I., HeardS.O.. A comparison of two antimicrobial-impregnated central venous catheters.N Engl J Med1999; 340: 1–8.
32.
BambauerR., LatzaR., BambauerS., TobinE.Large bore catheters with surface treatments versus untreated catheters for vascular access in hemodialysis.Int J Artif Organs2004; 28: 604–10.
33.
BleyerA., MasonL., RaadI., SherertzR.A randomized double blind trial comparing minocycline/EDTA with heparin as flush solutions for hemodialysis catheters. Program and abstracts of 4th Decennial Conference Program committee. March 5-9, 2000; Atlanta, GA.
34.
VijayvargiyaR., VeisJ.H.Antibiotic-resistant endocarditis in a hemodialysis patient.J Am Soc Nephrol1996; 7: 536–42.
35.
Fernandez-CeanJ., AlvarezA., BurguezS., BaldovinosG., Larre-BorgesP., ChaM.Infective endocarditis in chronic hemodialysis: two treatment strategies.Nephrol Dial Transplant2002; 17: 2226–30.
36.
HoenB.Infective endocarditis: a frequent disease in dialysis patients.Nephrol Dial Transplant2004; 19: 1360–2.
37.
MermelL.A., FarrB.M., SherertzR.J., RaadI.I., O'GradyN., HarrisJ.S., CravenD.E.Guidelines for the management of intravascular catheter-related infections.Clin Infect Dis2001; 32: 1249–72.